A scalable, aggregated genotypic–phenotypic database for human disease variation
暂无分享,去创建一个
Gilad Mishne | Jeremy Ginsberg | Ryan Barrett | Cynthia L. Neben | Anjali D. Zimmer | Wendy McKennon | Alicia Y. Zhou | G. Mishne | J. Ginsberg | A. Zhou | C. Neben | Ryan Barrett | Wendy McKennon
[1] M. King,et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.
[2] Kenneth Offit,et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1% , 1996, Nature Genetics.
[3] P. Hartge,et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.
[4] M Feychting,et al. Cancer in twins: genetic and nongenetic familial risk factors. , 1997, Journal of the National Cancer Institute.
[5] B. Weber,et al. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. , 1997, American journal of human genetics.
[6] R. Sanson-Fisher,et al. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline. , 1999 .
[7] R W Sanson-Fisher,et al. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. , 1999, American journal of preventive medicine.
[8] P Rozen,et al. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. , 1999, Gastroenterology.
[9] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[10] Päivi Heikkilä,et al. CHEK2 variant I157T may be associated with increased breast cancer risk , 2004, International journal of cancer.
[11] Charis Eng,et al. Highly penetrant hereditary cancer syndromes , 2004, Oncogene.
[12] Kenneth Offit,et al. Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population. , 2005, Human molecular genetics.
[13] S. Brandt-Rauf,et al. Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease. , 2006, American journal of public health.
[14] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[15] Heng Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM , 2013, 1303.3997.
[16] Ryan M. Layer,et al. LUMPY: a probabilistic framework for structural variant discovery , 2012, Genome Biology.
[17] Anh-Dao Nguyen,et al. Clinical Genomic Database , 2013, Proceedings of the National Academy of Sciences.
[18] Yuya Kobayashi,et al. Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. Narod,et al. Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.
[20] Nazneen Rahman,et al. Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.
[21] Tina Pesaran,et al. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients , 2014, Genetics in Medicine.
[22] Deanna M. Church,et al. ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..
[23] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[24] Wendy K Chung,et al. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing , 2015, Genetics in Medicine.
[25] Eric Talevich,et al. CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing , 2016, PLoS Comput. Biol..
[26] Yuan Xue,et al. Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing@@@Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing , 2016 .
[27] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[28] Diana Torres,et al. Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review. , 2016, The oncologist.
[29] J. Rajpura,et al. Consistency between Self-Reported and Recorded Values for Clinical Measures , 2016, Cardiology research and practice.
[30] Allison P. Heath,et al. Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.
[31] John Kidd,et al. Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Yuan Xue,et al. Genetic evaluation and testing for hereditary forms of cancer in the era of next-generation sequencing , 2016, Cancer biology & medicine.
[33] Steven N. Hart,et al. The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk , 2017, npj Breast Cancer.
[34] Karen Y He,et al. Big Data Analytics for Genomic Medicine , 2017, International journal of molecular sciences.
[35] Beth Crawford,et al. Multi-gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients , 2017, Breast Cancer Research and Treatment.
[36] Robert Huether,et al. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer , 2017, JAMA oncology.
[37] Sobia Raza,et al. Genomic medicine and data sharing , 2017, British medical bulletin.
[38] Jordan Lerner-Ellis,et al. PALB2 mutations in high-risk women with breast or ovarian cancer. , 2017 .
[39] Christopher P. Childers,et al. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer , 2018, JAMA oncology.
[40] Anjali D. Zimmer,et al. Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative , 2018, Journal of the National Cancer Institute.
[41] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .